Dapagliflozin in Patients with Chronic Kidney DiseaseHiddo J.L. Heerspink, David C. Wheeler, Bergur V. Stefánsson et al.|New England Journal of Medicine|2020Cited by 5.2k
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 DiabetesGeorge L. Bakris, Rajiv Agarwal, Stefan D. Anker et al.|New England Journal of Medicine|2020Cited by 2.6k
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J. Davies, John B. Buse, Vanita R. Aroda et al.|Diabetes Care|2022Cited by 1.9k
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 DiabetesVlado Perkovic, Richard Pratley, Katherine R. Tuttle et al.|New England Journal of Medicine|2024Cited by 1.5k
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysisCaroline S. Fox, Robert G. Nelson, Kunihiro Matsushita et al.|The Lancet|2012Cited by 1.4k